154 related articles for article (PubMed ID: 32671979)
1. The role of staging Computed Tomography on detection of occult metastasis in asymptomatic breast cancer patients.
Rajasooriyar C; Sritharan T; Chenthuran S; Indranath K; Surenthirakumaran R
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1247. PubMed ID: 32671979
[TBL] [Abstract][Full Text] [Related]
2. Preoperative PET/CT in early-stage breast cancer.
Bernsdorf M; Berthelsen AK; Wielenga VT; Kroman N; Teilum D; Binderup T; Tange UB; Andersson M; Kjær A; Loft A; Graff J
Ann Oncol; 2012 Sep; 23(9):2277-2282. PubMed ID: 22357250
[TBL] [Abstract][Full Text] [Related]
3. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced computed tomography detection of occult breast cancers presenting as axillary masses.
Akashi-Tanaka S; Fukutomi T; Miyakawa K; Uchiyama N; Nanasawa T; Tsuda H
Breast Cancer Res Treat; 1999 May; 55(1):97-101. PubMed ID: 10472784
[TBL] [Abstract][Full Text] [Related]
5. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
6. Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
McCartan DP; Prichard RS; MacDermott RJ; Rothwell J; Geraghty J; Evoy D; Quinn CM; Skehan SJ; O'Doherty A; McDermott EW
Br J Surg; 2016 Jun; 103(7):839-44. PubMed ID: 27004443
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer.
Liu Y; Bellomi M; Gatti G; Ping X
Breast Cancer Res; 2007; 9(4):R40. PubMed ID: 17615058
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Koolen BB; van der Leij F; Vogel WV; Rutgers EJ; Vrancken Peeters MJ; Elkhuizen PH; Valdés Olmos RA
Acta Oncol; 2014 Jan; 53(1):50-7. PubMed ID: 23672678
[TBL] [Abstract][Full Text] [Related]
9. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
10. Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.
García Vicente AM; Soriano Castrejón A; Cruz Mora MÁ; Ortega Ruiperez C; Espinosa Aunión R; León Martín A; González Ageitos A; Van Gómez López O
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):1-5. PubMed ID: 23707190
[TBL] [Abstract][Full Text] [Related]
11. Radiological Staging for Distant Metastases in Breast Cancer Patients with Confirmed Local and/or Locoregional Recurrence: How Useful are Current Guideline Recommendations?
Elfgen C; Schmid SM; Tausch CJ; Montagna G; Güth U
Ann Surg Oncol; 2019 Oct; 26(11):3455-3461. PubMed ID: 31332637
[TBL] [Abstract][Full Text] [Related]
12. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
13. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
[TBL] [Abstract][Full Text] [Related]
14. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
[TBL] [Abstract][Full Text] [Related]
16. PET/CT with
Teixeira SC; Koolen BB; Elkhuizen PH; Vrancken Peeters MT; Stokkel MP; Rodenhuis S; van der Noort V; Rutgers EJ; Valdés Olmos RA
Eur J Surg Oncol; 2017 Apr; 43(4):625-635. PubMed ID: 27847287
[TBL] [Abstract][Full Text] [Related]
17. Accurate staging with internal mammary chain sentinel node biopsy for breast cancer.
Gnerlich JL; Barreto-Andrade JC; Czechura T; John JR; Turk MA; Kennedy TJ; Winchester DJ
Ann Surg Oncol; 2014 Feb; 21(2):368-74. PubMed ID: 24046119
[TBL] [Abstract][Full Text] [Related]
18. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
[TBL] [Abstract][Full Text] [Related]
19. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Kim WH; Lee SW; Kim HJ; Chae YS; Jeong SY; Jung JH; Park HY; Lee WK
Sci Rep; 2018 Feb; 8(1):3181. PubMed ID: 29453385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
